nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—Epiphyses premature fusion—Tretinoin—peripheral nervous system neoplasm	0.119	0.13	CcSEcCtD
Nandrolone decanoate—Epiphyses premature fusion—Isotretinoin—peripheral nervous system neoplasm	0.119	0.13	CcSEcCtD
Nandrolone decanoate—Epiphyses premature fusion—Alitretinoin—peripheral nervous system neoplasm	0.0904	0.0982	CcSEcCtD
Nandrolone decanoate—Azoospermia—Cisplatin—peripheral nervous system neoplasm	0.0206	0.0224	CcSEcCtD
Nandrolone decanoate—Hoarseness—Tretinoin—peripheral nervous system neoplasm	0.0195	0.0212	CcSEcCtD
Nandrolone decanoate—Hoarseness—Isotretinoin—peripheral nervous system neoplasm	0.0195	0.0212	CcSEcCtD
Nandrolone decanoate—Local reaction—Tretinoin—peripheral nervous system neoplasm	0.0155	0.0169	CcSEcCtD
Nandrolone decanoate—Local reaction—Isotretinoin—peripheral nervous system neoplasm	0.0155	0.0169	CcSEcCtD
Nandrolone decanoate—Local reaction—Melphalan—peripheral nervous system neoplasm	0.0153	0.0166	CcSEcCtD
Nandrolone decanoate—Hoarseness—Alitretinoin—peripheral nervous system neoplasm	0.0148	0.0161	CcSEcCtD
Nandrolone decanoate—Hirsutism—Tretinoin—peripheral nervous system neoplasm	0.0148	0.0161	CcSEcCtD
Nandrolone decanoate—Hirsutism—Isotretinoin—peripheral nervous system neoplasm	0.0148	0.0161	CcSEcCtD
Nandrolone decanoate—Oligospermia—Epirubicin—peripheral nervous system neoplasm	0.0136	0.0148	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0126	0.0137	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0126	0.0137	CcSEcCtD
Nandrolone decanoate—Oligospermia—Doxorubicin—peripheral nervous system neoplasm	0.0126	0.0137	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Tretinoin—peripheral nervous system neoplasm	0.0119	0.0129	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Isotretinoin—peripheral nervous system neoplasm	0.0119	0.0129	CcSEcCtD
Nandrolone decanoate—Local reaction—Alitretinoin—peripheral nervous system neoplasm	0.0118	0.0128	CcSEcCtD
Nandrolone decanoate—Hirsutism—Alitretinoin—peripheral nervous system neoplasm	0.0112	0.0122	CcSEcCtD
Nandrolone decanoate—Azoospermia—Epirubicin—peripheral nervous system neoplasm	0.0106	0.0115	CcSEcCtD
Nandrolone decanoate—Dysphonia—Tretinoin—peripheral nervous system neoplasm	0.0104	0.0113	CcSEcCtD
Nandrolone decanoate—Dysphonia—Isotretinoin—peripheral nervous system neoplasm	0.0104	0.0113	CcSEcCtD
Nandrolone decanoate—Acne—Tretinoin—peripheral nervous system neoplasm	0.0102	0.0111	CcSEcCtD
Nandrolone decanoate—Acne—Isotretinoin—peripheral nervous system neoplasm	0.0102	0.0111	CcSEcCtD
Nandrolone decanoate—Azoospermia—Doxorubicin—peripheral nervous system neoplasm	0.00979	0.0106	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Melphalan—peripheral nervous system neoplasm	0.00965	0.0105	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00955	0.0104	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Alitretinoin—peripheral nervous system neoplasm	0.00904	0.00981	CcSEcCtD
Nandrolone decanoate—Dysphonia—Alitretinoin—peripheral nervous system neoplasm	0.00792	0.0086	CcSEcCtD
Nandrolone decanoate—Acne—Alitretinoin—peripheral nervous system neoplasm	0.00774	0.00841	CcSEcCtD
Nandrolone decanoate—MAOB—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.00755	0.0954	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.00744	0.0939	CbGpPWpGaD
Nandrolone decanoate—Furunculosis—Epirubicin—peripheral nervous system neoplasm	0.0067	0.00728	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00631	0.0796	CbGpPWpGaD
Nandrolone decanoate—Furunculosis—Doxorubicin—peripheral nervous system neoplasm	0.0062	0.00674	CcSEcCtD
Nandrolone decanoate—Irritability—Isotretinoin—peripheral nervous system neoplasm	0.00595	0.00647	CcSEcCtD
Nandrolone decanoate—Irritability—Tretinoin—peripheral nervous system neoplasm	0.00595	0.00647	CcSEcCtD
Nandrolone decanoate—Furuncle—Epirubicin—peripheral nervous system neoplasm	0.00581	0.00631	CcSEcCtD
Nandrolone decanoate—Furuncle—Doxorubicin—peripheral nervous system neoplasm	0.00538	0.00584	CcSEcCtD
Nandrolone decanoate—Fluid retention—Cisplatin—peripheral nervous system neoplasm	0.00527	0.00572	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—peripheral nervous system neoplasm	0.00515	0.00559	CcSEcCtD
Nandrolone decanoate—Local reaction—Doxorubicin—peripheral nervous system neoplasm	0.00476	0.00517	CcSEcCtD
Nandrolone decanoate—MAOA—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.00474	0.0599	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00462	0.00502	CcSEcCtD
Nandrolone decanoate—Irritability—Alitretinoin—peripheral nervous system neoplasm	0.00451	0.0049	CcSEcCtD
Nandrolone decanoate—MAOA—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.00423	0.0534	CbGpPWpGaD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00418	0.00454	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—peripheral nervous system neoplasm	0.00395	0.00429	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.00392	0.00426	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00387	0.0042	CcSEcCtD
Nandrolone decanoate—Irritability—Cisplatin—peripheral nervous system neoplasm	0.00384	0.00418	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.00384	0.00417	CcSEcCtD
Nandrolone decanoate—MAOB—Alpha-synuclein signaling—TH—peripheral nervous system neoplasm	0.00377	0.0476	CbGpPWpGaD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—peripheral nervous system neoplasm	0.00366	0.00397	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.00363	0.00394	CcSEcCtD
Nandrolone decanoate—Dysphonia—Epirubicin—peripheral nervous system neoplasm	0.00346	0.00376	CcSEcCtD
Nandrolone decanoate—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00324	0.00352	CcSEcCtD
Nandrolone decanoate—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00324	0.00352	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Epirubicin—peripheral nervous system neoplasm	0.00324	0.00352	CcSEcCtD
Nandrolone decanoate—Dysphonia—Doxorubicin—peripheral nervous system neoplasm	0.0032	0.00348	CcSEcCtD
Nandrolone decanoate—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00307	0.00333	CcSEcCtD
Nandrolone decanoate—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00307	0.00333	CcSEcCtD
Nandrolone decanoate—Oedema—Melphalan—peripheral nervous system neoplasm	0.00303	0.00329	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.003	0.00326	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.00284	0.00308	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00279	0.0352	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00277	0.00301	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—peripheral nervous system neoplasm	0.00271	0.00294	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00251	0.00273	CcSEcCtD
Nandrolone decanoate—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00251	0.00272	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.0025	0.00272	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00246	0.0311	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00267	CcSEcCtD
Nandrolone decanoate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00246	0.00267	CcSEcCtD
Nandrolone decanoate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00244	0.00265	CcSEcCtD
Nandrolone decanoate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00244	0.00265	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—COX2—peripheral nervous system neoplasm	0.00241	0.0304	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0024	0.00261	CcSEcCtD
Nandrolone decanoate—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00237	0.00257	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00237	0.00257	CcSEcCtD
Nandrolone decanoate—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00232	0.00252	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.0023	0.0025	CcSEcCtD
Nandrolone decanoate—Oedema—Vincristine—peripheral nervous system neoplasm	0.00224	0.00243	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00219	0.00238	CcSEcCtD
Nandrolone decanoate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00219	0.00237	CcSEcCtD
Nandrolone decanoate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00217	0.00236	CcSEcCtD
Nandrolone decanoate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00217	0.00236	CcSEcCtD
Nandrolone decanoate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00214	0.00233	CcSEcCtD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—BDNF—peripheral nervous system neoplasm	0.0021	0.0265	CbGpPWpGaD
Nandrolone decanoate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00198	0.00215	CcSEcCtD
Nandrolone decanoate—Rash—Topotecan—peripheral nervous system neoplasm	0.00195	0.00212	CcSEcCtD
Nandrolone decanoate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00195	0.00211	CcSEcCtD
Nandrolone decanoate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.0021	CcSEcCtD
Nandrolone decanoate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00193	0.0021	CcSEcCtD
Nandrolone decanoate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00193	0.0021	CcSEcCtD
Nandrolone decanoate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.0021	CcSEcCtD
Nandrolone decanoate—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00192	0.00208	CcSEcCtD
Nandrolone decanoate—Rash—Melphalan—peripheral nervous system neoplasm	0.00191	0.00207	CcSEcCtD
Nandrolone decanoate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00191	0.00207	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00185	0.0233	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.002	CcSEcCtD
Nandrolone decanoate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00184	0.00199	CcSEcCtD
Nandrolone decanoate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00198	CcSEcCtD
Nandrolone decanoate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00198	CcSEcCtD
Nandrolone decanoate—Nausea—Melphalan—peripheral nervous system neoplasm	0.0018	0.00195	CcSEcCtD
Nandrolone decanoate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00179	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00159	0.0201	CbGpPWpGaD
Nandrolone decanoate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00158	0.00172	CcSEcCtD
Nandrolone decanoate—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00155	0.00169	CcSEcCtD
Nandrolone decanoate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00149	0.00162	CcSEcCtD
Nandrolone decanoate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00159	CcSEcCtD
Nandrolone decanoate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00159	CcSEcCtD
Nandrolone decanoate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00144	0.00156	CcSEcCtD
Nandrolone decanoate—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00156	CcSEcCtD
Nandrolone decanoate—Rash—Vincristine—peripheral nervous system neoplasm	0.00141	0.00153	CcSEcCtD
Nandrolone decanoate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00141	0.00153	CcSEcCtD
Nandrolone decanoate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.0015	CcSEcCtD
Nandrolone decanoate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00133	0.00144	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00129	0.0014	CcSEcCtD
Nandrolone decanoate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00128	0.00139	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.00125	0.0158	CbGpPWpGaD
Nandrolone decanoate—Rash—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00136	CcSEcCtD
Nandrolone decanoate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00135	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00125	0.0157	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.0013	CcSEcCtD
Nandrolone decanoate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00128	CcSEcCtD
Nandrolone decanoate—Rash—Etoposide—peripheral nervous system neoplasm	0.00114	0.00124	CcSEcCtD
Nandrolone decanoate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00114	0.00124	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00114	0.0144	CbGpPWpGaD
Nandrolone decanoate—Nausea—Etoposide—peripheral nervous system neoplasm	0.00108	0.00117	CcSEcCtD
Nandrolone decanoate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00117	CcSEcCtD
Nandrolone decanoate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00102	0.0011	CcSEcCtD
Nandrolone decanoate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000995	0.00108	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000981	0.0124	CbGpPWpGaD
Nandrolone decanoate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000941	0.00102	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000825	0.0104	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000808	0.000877	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000803	0.0101	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000747	0.000812	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000737	0.00931	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000736	0.00929	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CDKN2A—peripheral nervous system neoplasm	0.000731	0.00924	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000719	0.000781	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00071	0.00896	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000709	0.00895	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000696	0.00879	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.000669	0.00845	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000666	0.000723	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000649	0.0082	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000646	0.00816	CbGpPWpGaD
Nandrolone decanoate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000641	0.000696	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00064	0.000696	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000635	0.00801	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000611	0.00771	CbGpPWpGaD
Nandrolone decanoate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000656	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.0006	0.00757	CbGpPWpGaD
Nandrolone decanoate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.000644	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.000644	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.000591	0.00746	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	0.000589	0.00743	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—AKT1—peripheral nervous system neoplasm	0.000568	0.00717	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000566	0.00715	CbGpPWpGaD
Nandrolone decanoate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000607	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000557	0.00703	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000529	0.00668	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.00051	0.00644	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000501	0.00633	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00047	0.00594	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000437	0.00552	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000434	0.00548	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EED—peripheral nervous system neoplasm	0.00043	0.00543	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000426	0.00538	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	0.000399	0.00504	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.000395	0.00499	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000344	0.00434	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—AKT1—peripheral nervous system neoplasm	0.000344	0.00434	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GNS—peripheral nervous system neoplasm	0.00034	0.00429	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NME1—peripheral nervous system neoplasm	0.000326	0.00412	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—COX2—peripheral nervous system neoplasm	0.000314	0.00396	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000307	0.00388	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.0003	0.00378	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000295	0.00373	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000288	0.00363	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000281	0.00354	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.000274	0.00346	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000265	0.00334	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000264	0.00334	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000255	0.00322	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000254	0.00321	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.00024	0.00303	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000239	0.00302	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GNS—peripheral nervous system neoplasm	0.000213	0.00269	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000208	0.00263	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000207	0.00261	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ENO2—peripheral nervous system neoplasm	0.000206	0.0026	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NME1—peripheral nervous system neoplasm	0.000205	0.00258	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	0.0002	0.00252	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000199	0.00251	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000197	0.00249	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—COX2—peripheral nervous system neoplasm	0.000197	0.00249	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000192	0.00243	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BCHE—peripheral nervous system neoplasm	0.000174	0.0022	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.00017	0.00214	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000166	0.0021	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000166	0.0021	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TH—peripheral nervous system neoplasm	0.000164	0.00207	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000163	0.00206	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000143	0.00181	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000138	0.00174	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GNAS—peripheral nervous system neoplasm	0.000134	0.00169	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000133	0.00168	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000131	0.00166	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ENO2—peripheral nervous system neoplasm	0.000129	0.00163	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000126	0.00159	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000109	0.00138	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000107	0.00135	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000104	0.00132	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TH—peripheral nervous system neoplasm	0.000103	0.0013	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000102	0.00129	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000102	0.00128	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	0.0001	0.00126	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	9.88e-05	0.00125	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GNAS—peripheral nervous system neoplasm	8.38e-05	0.00106	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCB1—peripheral nervous system neoplasm	8.23e-05	0.00104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	8.18e-05	0.00103	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.02e-05	0.00101	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—peripheral nervous system neoplasm	4.76e-05	0.000601	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—peripheral nervous system neoplasm	3.61e-05	0.000455	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—peripheral nervous system neoplasm	3.3e-05	0.000417	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—peripheral nervous system neoplasm	2.26e-05	0.000286	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.21e-05	0.000279	CbGpPWpGaD
